Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
ALL, Biological, Leukemia, SARS-CoV-2/COVID-19, CLL, Diseases, Lymphoma (any), CAR-Ts, Mantle Cell Lymphoma, Therapies, Non-Hodgkin Lymphoma, Biological Processes, cell expansion, T-Cell Lymphoma, Technology and Procedures, immunotherapy, Lymphoid Malignancies, Clinically relevant, hematopoiesis, flow cytometry, immune mechanism, mass cytometry, molecular interactions
	Type: Oral
Hematology Disease Topics & Pathways:
ALL, Biological, Leukemia, SARS-CoV-2/COVID-19, CLL, Diseases, Lymphoma (any), CAR-Ts, Mantle Cell Lymphoma, Therapies, Non-Hodgkin Lymphoma, Biological Processes, cell expansion, T-Cell Lymphoma, Technology and Procedures, immunotherapy, Lymphoid Malignancies, Clinically relevant, hematopoiesis, flow cytometry, immune mechanism, mass cytometry, molecular interactions
Monday, December 7, 2020: 7:00 AM-8:30 AM
	
	
	
	
	   
			
		Moderators:
			
				
				
					
						
						
						
							Jennifer N. Brudno, MD, National Cancer Institute, National Institutes of Health
						
					
					
				
					
						 and 
						
						
							Nathan Singh, MD, University of Pennsylvania
						
					
					
				
			
 
			
			Disclosures:
			
			
				
			
				
			
			No relevant conflicts of interest to declare.
			 
		7:00 AM
	
	
7:15 AM
	
	
7:30 AM
	
	
8:00 AM
	
	
	
	
	See more of: Oral and Poster Abstracts
	
	
	
	
	*signifies non-member of ASH
					
 denotes an abstract that is clinically relevant.
 denotes an abstract that is clinically relevant. denotes that this is a recommended PHD Trainee Session.
 denotes that this is a recommended PHD Trainee Session. denotes that this is a ticketed session.
 denotes that this is a ticketed session.